Icon is pleased to welcome Shuling Sum as Chief Operating Officer for ASEAN, strengthening regional operational leadership across Icon’s sites in Singapore, Malaysia and Indonesia.
As Icon’s ASEAN footprint continues to mature and scale, the establishment of the COO role marks an important next phase in the region’s growth, enhancing operational leadership to drive greater consistency, capability and integration as Icon continues to expand access to high‑quality cancer care.
In this senior leadership role, Shuling will be responsible for the safe, effective and efficient operation of Icon sites across the region, supporting the delivery of exceptional patient care.
The COO role will strengthen operational excellence and collaboration with clinical leaders to ensure Icon’s continued leadership in the delivery of holistic cancer care. Beyond this, Shuling will be pivotal in leveraging Icon Group’s global network of services and innovative models of care to enhance the patient experience across our ASEAN portfolio of centres.
Shuling brings extensive healthcare leadership experience across operations, transformation and strategic growth. She has held senior roles within IHH Healthcare, including Head of Laboratory Services at Parkway Laboratories and Assistant Vice President, Group Strategy and Business Development, where she supported multi-market operating models, performance frameworks, and regional development initiatives. She has also contributed to greenfield hospital operations and led teams responsible for hospital revenue operations, engagement and service recovery.
Shuling holds an MBA from The Hong Kong University of Science and Technology and a Bachelor of Science from The University of British Columbia.
“Icon’s commitment to delivering high‑quality, patient‑centred cancer care across the region is something I deeply admire. I’m excited to be joining the team at this stage of ASEAN’s growth to strengthen operational consistency and work closely with our clinicians and teams to deliver exceptional care for every patient,” Shuling said.
CEO Icon ASEAN, Serena Wee said Shuling will be a strong addition to ASEAN’s leadership team.
“Shuling brings strong operational discipline, a genuine focus on patient experience, and deep experience working across complex healthcare environments,” said Serena.
“Her leadership will help us continue strengthening how we operate across the region, supporting our clinicians and teams to deliver safe, consistent, high-quality care for every patient.”
Shuling Sum commences with Icon ASEAN on 2 June 2026.